NCT00188565View on ClinicalTrials.gov

Celebrex With Preoperative Chemoradiation - Rectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Colorectal Neoplasms
Interventions
DRUG

Celecoxib

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Ontario Cancer Research Network

NETWORK

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00188565 - Celebrex With Preoperative Chemoradiation - Rectal Cancer | Biotech Hunter | Biotech Hunter